On a mission to provide knowledge & advance #clinicaltrial sites. eSource, CTMS, patient recruiting software that's built for sites. #clinicalresearch blog.
The Remdesivir placebo-controlled randomized trial data.
We've eagerly awaited the data; now published @NEJM https://t.co/zm1uAaPAjD
Significant benefit for 27% ⬇️time to recovery, across all subgroups except those on a ventilator/ECMO, death reduced 30% (95% CI 0.47, 1.04; NS)
Learn how Joel Ebuh of Gadolin Research and Karen Obmaces of Accurate Clinical Research successfully negotiated new and existing sponsor budgets. By negotiating wisely, you can lay the foundation for a strong second half.
https://t.co/V0CN12ODcD
Edye Edens of First Class Solutions reports that sites have a strong case for renegotiating trial budgets given the current environment of increased regulatory change and offers insight on how to tackle this conversation with sponsors.
https://t.co/mWEy2luzmB
Matt Clair of Precision Recruitment reports that most studies have been put on enrollment hold. However, now is an excellent time to reach patients and a great opportunity to nurture your patient relationships and build your pre-qualification lists.
https://t.co/LKT3CJ4hCX
Rachel Truxall of Insearch Development discusses how sponsors are reacting to the current covid crisis, the looming phase 2 COVID treatment and vaccine trials, and the potential for a spike in trial activity once the holds are lifted.
https://t.co/J79uTlMuj9
James Riddle, Advarra's VP of Institutional Services, provides insights on how his IRB is responding to COVID-related requests, the rise of virtual and at-home visits, and how the FDA's most recent guidance offers flexibility to sponsors and sites alike.
https://t.co/F25HELUzNI
Near ground zero of the first Australian death from coronavirus and running cancer trials amidst an environment of travel restrictions, Linear Clinical Research accelerated its adoption of a remote monitoring model using CRIO's eSource/eRegulatory system.
https://t.co/hBVweiNKao
Join us as Molly Downhour of Medix distills years of practice into 10 practical tips. Following these practices could increase your budgets by as much as 20% - which can be the difference between profit and loss!
https://t.co/4kF2msPXL6
Anthony Abey, a site network CEO, has built a sophisticated centralized phone screening process to maximize patient recruitment. Learn how he screens patients accurately and quickly, giving his sites an enormous recruiting edge!
https://t.co/5CnoEN8UwK
Join Jill Heinz (@KTNLE ), CEO of @IFCR_Boise, as she shares her tips and tricks to help you bring in leads with minimal effort. Through trial and error, Jill went from having virtually no organic traffic to now averaging 20 patient leads per month!
https://t.co/sSDlOvLKRs
Join Chinonso Singleton, Director of Training and HR at @DelRicht Research, as she walks through DelRicht’s rigorous and effective hiring process. Learn her best practices and advice to build a long-term, successful research team.
https://t.co/vRTdqIVmDo
Join Sean Rice, CEO of Medical Research Alliance and Co-Founder of @DevanaSolutions, as he discusses the 5 metrics every site should track when working with sponsors!
https://t.co/r0mJa5TrPt
Is your Regulatory Specialist chained to the copier? Break them free with CRIO's eRegulatory solution! Learn more about the Common File workflow and how it can benefit your research site. #eReg#research#efficiency
https://t.co/ighM56rf2L
Clinical Research Sites are always looking for ways to cut down ❌ on deviations.
Today there are new workflow tools to do just that! 👍
Learn from Medex Healthcare Research: https://t.co/MeCJzTM9TR
Do you still have piles of paper at your paperless research site? BOOKMARK🔖 this article. ⤵️
https://t.co/BIR3O6eu4U
Find out what documents you can make electronic and what you should keep on paper. #eSource#eReg#clinicaltrials
Looking to free up 30% of your Coordinator's time, so they can recruit more patients!? @PBRCenter has proven through their eSource workflows just how to do it. #clinicaltrials#eSource#time
https://t.co/zRY2WgUne5